Completed Somatostatin Receptor Imaging in NPC, EBV Related Cancers NCT05581550 Conditions Epstein-Barr Virus Related Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Cancer, +9 more Locations National Cancer Centre Singapore — Singapore View Trial Details
Active, Not Recruiting Novel Small Molecule EBNA1 Inhibitor, VK 2019, in Patients With Epstein Barr Virus (EBV)-Positive Nasopharyngeal Cancer (NPC) and Other Epstein-Barr Virus (EBV)-Associated Cancers, With Pharmacokinetic and Pharmacodynamic Correlative Studies NCT04925544 Conditions Carcinoma, DNA Virus Infections, Epstein-Barr Virus Infections, +19 more Locations Stanford University — Stanford, California, United States View Trial Details
